MétaCan
Menu
Back to cohort

Comparison of patient characteristics and chromosomal abnormalities by first-line treatment in chronic lymphoid leukemia (CLL) patients in Canada.

2015· article· en· W2920928707 on OpenAlexaffabout
Marc Lapierre

Bibliographic record

VenueJournal of Clinical Oncology · 2015
Typearticle
Languageen
FieldMedicine
TopicChronic Lymphocytic Leukemia Research
Canadian institutionsMerck Canada Inc. (Canada)
Fundersnot available
KeywordsFludarabineBendamustineMedicineChlorambucilChronic lymphocytic leukemiaInternal medicineOncologyLeukemiaChemotherapyCyclophosphamide

Abstract

fetched live from OpenAlex

e18029 Background: With recent approval of targeted agents and continued development of novel therapies, the first-line treatment of patients with chronic lymphocytic leukemia (CLL) has undergone a significant evolution in the past year. This retrospective study investigates patient characteristics and genetic abnormalities by first-line treatment choice in CLL patients in Canada. Methods: This study utilized IMS Brogan Enhanced Tumor Studies, an anonymised patient database collected through quarterly physician panel survey, which provides comprehensive insight into total cancer care. Patient characteristics (including age, co-morbidities and ECOG performance status), genetic markers and first-line drug treatments were identified in CLL patients treated in Canada between October 2013 and September 2014. Results: See Table. Analysis of 273 first-line CLL patients identified that younger patients (≤70) with more favorable disease characteristics (co-morbidities=0-1, good renal function, & ECOG=0-1) were predominantly treated with fludarabine-based regimens in the first-line. Older patients (>70) with less favorable disease characteristics (co-morbidities=2+, renal disease & ECOG=2-3) were mostly treated with chlorambucil-based regimens, bendamustine-based regimens and novel treatments in the first-line (see table). Of the 190 first-line CLL patients (70%) that were tested for chromosome abnormalities, 63% tested positive. 53% of patients possessing deletion 13q or trisomy 12 abnormalities were prescribed fludarabine-based regimens. Conversely, 44% of patients with 17p or 11q deletions were prescribed chlorambucil-based regimens. Conclusions: The analysis of first-line CLL patients in this study has identified differences in patient fitness and genetic markers. It therefore demonstrates the importance of these factors in determining treatment choice. First-line Treatment FLUD-based (exc. FCR) (n=75) FCR (n=45) CHLOR-based (n=78) BEND-based (n=21) NOVEL (n=5) Age ≤70: 68% ≤70: 86% >70: 59% >70: 62% >70: 25% Co-morbidities 0-1: 87% 0-1: 82% 2+: 41% 2+: 48% 2+: 40% Renal Disease 4% 9% 12% 29% 20% ECOG Status 0-1: 63% 0-1: 72% 2-3: 36% 2-3: 52% 2-3: 60%

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.050
Threshold uncertainty score0.118

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.004
Science and technology studies0.0020.000
Scholarly communication0.0010.000
Open science0.0010.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.100
GPT teacher head0.431
Teacher spread0.331 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2015
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicChronic Lymphocytic Leukemia ResearchFrench-language works237,207